Relation between Endothelial Nitric Oxide Synthase Genotypes and Oxidative Stress Markers in Larynx Cancer

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Yanar, K ^a   Cakatay U ^a   Aydin, S ^a   Verim, A ^b   Atukeren, P ^a   Ozkan N E ^a   Karatoprak, K ^a   Cebe, T ^a   Turan, S ^a   Ozkok E ^a   Korkmaz, G ^a   Cacina, C ^a   Kucukhuseyin O ^a   Yaylim, I ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; ENZYMES; OXIDATION; OXYGEN; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROTEINS; ZINC;

ADVANCED OXIDATION; AMINO ACID SUBSTITUTION; CU ,ZN SUPEROXIDE DISMUTASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LIPID HYDROPEROXIDES; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS MARKERS; STATISTICAL SIGNIFICANCE;

NITRIC OXIDE;

ADVANCED OXIDATION PROTEIN PRODUCT; ANTIOXIDANT; CARBONYL DERIVATIVE; COPPER ZINC SUPEROXIDE DISMUTASE; G PROTEIN COUPLED RECEPTOR; GENOMIC DNA; HYDROXYL RADICAL; LIPID HYDROPEROXIDE; NITRIC OXIDE SYNTHASE; THIOL GROUP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CANCER GENETICS; CANCER RECURRENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; FENTON REACTION; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LARYNX SQUAMOUS CELL CARCINOMA; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; CASE CONTROL STUDY; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETICS; LARYNX TUMOR; METABOLISM;

BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; LARYNGEAL NEOPLASMS; MALE; NEOPLASM PROTEINS; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; POLYMORPHISM, GENETIC;

EID: 84949309307     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/4985063     Document Type: Article

References (46)

1. M. Nilsson, W.-H. Chow, M. Lindblad, andW. Ye, "No association between gastroesophageal reflux and cancers of the larynx and pharynx, " Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 5, pp. 1194-1197, 2005.
2. A. Báez, "Genetic and environmental factors in head and neck cancer genesis, " Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews, vol. 26, no. 2, pp. 174-200, 2008.
3. C. Üneri, M. Sari, T. Ba?glam, S?. Polat, and M. Yüksel, "Effects of vitamin E on cigarette smoke induced oxidative damage in larynx and lung, " Laryngoscope, vol. 116, no. 1, pp. 97-100, 2006.
4. R. C. Dwivedi, D. P. Raturi, N. Kandpal, R. C. Dwivedi, R. P. Singh, and V. N. Puri, "Oxidative stress in patients with laryngeal carcinoma, " Indian Journal of Cancer, vol. 45, no. 3, pp. 97-99, 2008.
5. P. Ja?oszyński, P. Jaruga, R. Oliński et al., "Oxidative DNA base modifications and polycyclic aromatic hydrocarbon DNA adducts in squamous cell carcinoma of larynx, " Free Radical Research, vol. 37, no. 3, pp. 231-240, 2003.
6. M. Tecder Ünal, H. G. Karabulut, G. Gümüs?-Akay et al., "Endothelial nitric oxide synthase gene polymorphism in gastric cancer, " Turkish Journal of Gastroenterology, vol. 21, no. 4, pp. 338-344, 2010.
7. E. W. J. A. Albrecht, C. A. Stegeman, P. Heeringa, R. H. Henning, and H. van Goor, "Protective role of endothelial nitric oxide synthase, " Journal of Pathology, vol. 199, no. 1, pp. 8-17, 2003.
8. L. Wang, G. G. Shi, J. C. Yao et al., "Expression of endothelial nitric oxide synthase correlates with the angiogenic phenotype of and predicts poor prognosis in human gastric cancer, " Gastric Cancer, vol. 8, no. 1, pp. 18-28, 2005.
9. J. Laitakari, V. Näyhä, and F. Stenbäck, "Size, shape, structure, and direction of angiogenesis in laryngeal tumour development, " Journal of Clinical Pathology, vol. 57, no. 4, pp. 394-401, 2004.
10. A. Franchi, O. Gallo, M. Paglierani et al., "Inducible nitric oxide synthase expression in laryngeal neoplasia: correlation with angiogenesis, "Head & Neck, vol. 24, no. 1, pp. 16-23, 2002.
11. A. Brankovíc, G. Braju?skovíc, Z. Nikolíc et al., "Endothelial nitric oxide synthase gene polymorphisms and prostate cancer risk in Serbian population, " International Journal of Experimental Pathology, vol. 94, no. 6, pp. 355-361, 2013.
12. Q.-H. Wang, J.-W. Zhang, Z.-X. Zhang, C.-B. Wu, and D. Chen, "Association between Alzheimer's disease and nitric oxide synthase III polymorphism, " Zhongguo Yi Xue Ke Xue Yuan Xue Bao, vol. 26, no. 2, pp. 112-115, 2004.
13. B. A. Veldman, W. Spiering, P. A. Doevendans et al., "The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide, " Journal of Hypertension, vol. 20, no. 10, pp. 2023-2027, 2002.
14. D. Trachootham, W. Lu, M. A. Ogasawara, N. R.-D. Valle, and P. Huang, "Redox regulation of cell survival, " Antioxidants & Redox Signaling, vol. 10, no. 8, pp. 1343-1374, 2008.
15. I. A. Y?lmaz, T. Akc?ay, U. C? akatay, A. Telci, S. Ataus, and V. Yalcn, "Relation between bladder cancer and protein oxidation, " International Urology and Nephrology, vol. 35, no. 3, pp. 345-350, 2003.
16. P. Atukeren, B. Yavuz, H. O. Soyd?nc et al., "Variations in systemic biomarkers of oxidative/nitrosative stress and DNA damage before and during the consequent two cycles of chemotherapy in breast cancer patients, " Clinical Chemistry and Laboratory Medicine, vol. 48, no. 10, pp. 1487-1495, 2010.
17. Z. Cai and L. J. Yan, "Protein oxidativemodifications: beneficial roles in disease and health, " Journal of Biomedical and Pharmaceutical Research, vol. 1, no. 1, pp. 15-26, 2013.
18. C. Szabó, H. Ischiropoulos, and R. Radi, "Peroxynitrite: biochemistry, pathophysiology and development of therapeutics, " Nature Reviews Drug Discovery, vol. 6, no. 8, pp. 662-680, 2007.
19. C. Capeillère-Blandin, V. Gausson, B. Descamps-Latscha, and V. Witko-Sarsat, "Biochemical and spectrophotometric significance of advanced oxidized protein products, " Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1689, no. 2, pp. 91-102, 2004.
20. T. Cebe, P. Atukeren, K. Yanar et al., "Oxidation scrutiny in persuaded aging and chronological aging at systemic redox homeostasis level, " Experimental Gerontology, vol. 57, pp. 132-140, 2014.
21. M. E. Sitar, S. Aydin, and U. C? akatay, "Human serum albumin and its relation with oxidative stress, " Clinical Laboratory, vol. 59, no. 9-10, pp. 945-952, 2013.
22. Y. Miyamoto, Y. Saito, N. Kajiyama et al., "Endothelial nitric oxide synthase gene is positively associated with essential hypertension, " Hypertension, vol. 32, no. 1, pp. 3-8, 1998.
23. S. A. Miller, D. D. Dykes, and H. F. Polesky, "A simple salting out procedure for extractingDNA fromhuman nucleated cells, " Nucleic Acids Research, vol. 16, no. 3, article 1215, 1988.
24. A. Z. Reznick and L. Packer, "Oxidative damage to proteins: spectrophotomtric method for carbonyl assay, " Methods in Enzymology, vol. 233, pp. 357-363, 1994.
25. M. Lenarczyk, E. P. Cohen, B. L. Fish et al., "Chronic oxidative stress as a mechanism for radiation nephropathy, " Radiation Research, vol. 171, no. 2, pp. 164-172, 2009.
26. M. Hanasand, R. Omdal, K. B. Norheim, L. G. Goransson, C. Brede, and G. Jonsson, "Improved detection of advanced oxidation protein products in plasma, " Clinica Chimica Acta, vol. 413, no. 9-10, pp. 901-906, 2012.
27. J. H. Zeng, Z. M. Zhong, X. D. Li et al., "Advanced oxidation protein products accelerate bone deterioration in aged rats, " Experimental Gerontology, vol. 50, pp. 64-71, 2014.
28. J. Sedlak and R. H. Lindsay, "Estimation of total, proteinbound, and nonprotein sulfhydryl groups in tissuewith Ellman's reagent, " Analytical Biochemistry, vol. 25, pp. 192-205, 1968.
29. S. P. Wolff, "Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides, " Methods in Enzymology, vol. 233, pp. 182-189, 1994.
30. Y. Sun, L. W. Oberley, and Y. A. Li, "A simple method for clinical assay of superoxide dismutase, " Clinical Chemistry, vol. 34, no. 3, pp. 497-500, 1988.
31. A. Acharya, I. Das, D. Chandhok, and T. Saha, "Redox regulation in cancer: A double-edged sword with therapeutic potential, " OxidativeMedicine and Cellular Longevity, vol. 3, no. 1, pp. 23-34, 2010.
32. E. Karaman, H. Uzun, I. Papila et al., "Serum paraoxonase activity and oxidative DNA damage in patients with laryngeal squamous cell carcinoma, " Journal of Craniofacial Surgery, vol. 21, no. 6, pp. 1745-1749, 2010.
33. L. C. Jadeski, C. Chakraborty, and P. K. Lala, "Nitric oxidemediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase, " International Journal of Cancer, vol. 106, no. 4, pp. 496-504, 2003.
34. L. Kong, G. D. Dunn, L. K. Keefer, and R. J. Korthuis, "Nitric oxide reduces tumor cell adhesion to isolated rat postcapillary venules, " Clinical and ExperimentalMetastasis, vol. 14, no. 4, pp. 335-343, 1996.
35. C. Ryk, N. P. Wiklund, T. Nyberg, and P. J. de Verdier, "Polymorphisms in nitric-oxide synthase 3 may influence the risk of urinary-bladder cancer, " Nitric Oxide, vol. 25, no. 3, pp. 338-343, 2011.
36. L. A. Hefler, E. Ludwig, D. Lampe et al., "Polymorphisms of the endothelial nitric oxide synthase gene in ovarian cancer, " Gynecologic Oncology, vol. 86, no. 2, pp. 134-137, 2002.
37. S. Terrazzino, P. LaMattina, L. Masini et al., "Common variants of eNOS and XRCC1 genes may predict acute skin toxicity in breast cancer patients receiving radiotherapy after breast conserving surgery, " Radiotherapy and Oncology, vol. 103, no. 2, pp. 199-205, 2012.
38. M. G. Colombo, M. G. Andreassi, U. Paradossi et al., "Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298?Asp polymorphism) to the presence, extent, and severity of coronary artery disease, " Heart, vol. 87, no. 6, pp. 525-528, 2002.
39. L. Ying and L. J. Hofseth, "An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer, " Cancer Research, vol. 67, no. 4, pp. 1407-1410, 2007.
40. D. Fukumura, S. Kashiwagi, and R. K. Jain, "The role of nitric oxide in tumour progression, " Nature Reviews Cancer, vol. 6, no. 7, pp. 521-534, 2006.
41. Z.-Q. Xu, V. A. Pieribone, X. Zhang, S. Grillner, and T. Hökfelt, "A functional role for nitric oxide in locus coeruleus: immunohistochemical and electrophysiological studies, " Experimental Brain Research, vol. 98, no. 1, pp. 75-83, 1994.
42. S. Haque, R. K. Mandal, N. Akhter et al., "G894T and 4a/b polymorphisms of NOS3 gene are not associated with cancer risk: A meta-analysis, " Asian Pacific Journal of Cancer Prevention, vol. 16, no. 7, pp. 2929-2937, 2015.
43. K. Pimková, L. Chrastinová, J. Suttnar et al., "Plasma levels of aminothiols, nitrite, nitrate, and malondialdehyde inmyelodysplastic syndromes in the context of clinical outcomes and as a consequence of iron overload, " OxidativeMedicine and Cellular Longevity, vol. 2014, Article ID 416028, 10 pages, 2014.
44. A. Wu, T. Duan, D. Tang et al., "Determination of nitric oxidederived nitrite and nitrate in biological samples by HPLC coupled to nitrite oxidation, " Chromatographia, vol. 76, no. 23-24, pp. 1649-1655, 2013.
45. M. Ritt, C. Ott, C. Delles, M. P. Schneider, and R. E. Schmieder, "Impact of the endothelial nitric oxide synthase gene G894T polymorphism on renal endothelial function in patients with type 2 diabetes, " Pharmacogenetics and Genomics, vol. 18, no. 8, pp. 699-707, 2008.
46. N. Breusing and T. Grune, "Biomarkers of protein oxidation from a chemical, biological and medical point of view, " Experimental Gerontology, vol. 45, no. 10, pp. 733-737, 2010.